• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Boston Scientific adds two blocked artery treatment devices | Acquisitions roundup

Boston Scientific adds two blocked artery treatment devices | Acquisitions roundup

February 16, 2011 By MassDevice staff

M and A Roundup

Boston Scientific Corp. (NYSE:BSX) is adding two blocked artery treatment technologies two its portfolio of vascular treatment devices.

The Natick, Mass.-based medical device giant acquired a re-entry catheter from Israel-based S.I. Therapies Ltd. in November, and, with the pending acquisition of ReVascular Therapeutics Inc., the company is adding an intraluminal chronic total occlusions (CTO) crossing device. Both devices treat peripheral CTOs.

Sunnyvale, Calif.-based ReVascular’s RVT CTO Device won 510(k) market clearance from the Food & Drug Administration in January.

A CTO, or totally blocked artery, can not "typically be treated with standard endovascular devices such as guidewires and other catheter-based technologies," according to Boston Scientific. CTO treatment devices give doctors and patients the option of treating blocked arteries that might require surgery or amputation, the company said.

BSX made the acquisitions because the devices cover areas with promise of high growth potential, according to CEO Ray Elliott.

“Our [growth initiatives] include peripheral vascular disease, in which a significant number of patients remain undiagnosed or untreated. Addressing these challenges through use of less-invasive devices could greatly improve the care these patients receive,” he said in prepared remarks.

Here’s a roundup of companies announcing mergers, acquisitions and divestitures.

  • Sonoma Orthopedic Products picks up NovaLign Orthopaedics assets
    Sonoma Orthopedic Products Inc. closed the acquisition of certain key assets of NovaLign Orthopaedics Inc. The acquired intellectual property, assets and licenses relate to novel intramedullary designs for least invasive fracture fixation. Complementary to Sonoma’s proprietary WaviBody Technology, it is another type of flexible-to-rigid science that allows implants to be inserted into bones in a flexible condition and then locked securely to hold fractures in place during healing. The acquired technology will be marketed under the TaperBody brand. TaperBody implants can be inserted without violating surrounding joints and are especially useful for long bone fractures. Sonoma expects to begin rolling out TaperBody products in Q2 of this year.
    Read more
  • Sciessent LLC acquires antimicrobial firm Agion Technologies
    Sciessent LLC, is pleased to announce the acquisition of the assets of Agion Technologies Inc., a leader in providing antimicrobial and odor control solutions for the consumer, industrial and healthcare industries. Founded and led by the senior management team of the former Agion Technologies, Sciessent anticipates a seamless transition for Agion Technologies’ customers.
    Read more
  • WellDoc takes over Oncology Care Home Health Specialists
    WellDoc, a healthcare technology company focused on positive behavior change and supports clinical decision making to improve health outcomes and reduce healthcare costs, acquired Oncology Care Home Health Specialists Inc., the nation’s only home health consulting company dedicated to oncology. The acquisition is accelerating the development and quality of the WellDoc mHealth oncology solution, one of several disease suites in development, and will complement WellDoc’s FDA cleared DiabetesManager. This new subsidiary of WellDoc, now renamed Oncology Care Home Health LLC, is a comprehensive education and consulting company dedicated to helping home health providers implement specialized oncology programs.
    Read more
  • BAE Systems completes purchase of L-1’s intelligence services group
    BAE Systems Inc. completed its acquisition of L-1 Identity Solutions Inc.’s intelligence services group (ISG), which is comprised of SpecTal LLC, Advanced Concepts Inc., and McClendon LLC, for a purchase price of approximately $297 million. The completed transaction, initially announced in September, will enhance BAE Systems’ ability to effectively meet the growing needs of government intelligence, defense and security customers. ISG employs more than 1,000 people, who are suppliers to the U.S. intelligence and defense community and the company’s operations will now become an integral, complementary part of BAE Systems’ growing Intelligence & Security sector.
    Read more

Filed Under: Business/Financial News, Mergers & Acquisitions, News Well Tagged With: Boston Scientific

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy